VisusNano Ltd. is a pre-clinical startup developing a drug-eluting intraocular lens implant for use in patients undergoing cataract surgery. By improving patient outcomes, obviating the need for eye drops after surgery, and avoiding the need for laser treatment after surgery, our project has the potential to revolutionize cataract surgery in both the human and veterinary markets.